Population-based statistics for women diagnosed with inflammatory breast cancer (United States).
about
Short- and long-term cause-specific survival of patients with inflammatory breast cancer.Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.Epidemiology of inflammatory breast cancer (IBC).Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosisLocoregional treatment outcomes after multimodality management of inflammatory breast cancerPrimary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancerInflammatory breast cancer in north Africa: comparison of clinical and molecular epidemiologic characteristics of patients from Egypt, Tunisia, and MoroccoInflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients.Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcomeAssociation of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007.Characterizing inflammatory breast cancer among Arab Americans in the California, Detroit and New Jersey Surveillance, Epidemiology and End Results (SEER) registries (1988-2008).Approach to inflammatory breast cancer.Histone deacetylase inhibitors modulate miRNA and mRNA expression, block metaphase, and induce apoptosis in inflammatory breast cancer cellsWhat can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma?What is inflammatory breast cancer? Revisiting the case definition.The occurrence of rare cancers in U.S. adults, 1995-2004.Inflammatory breast cancer: what are the treatment options?Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation.Biology and management of inflammatory breast cancer.Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells.Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system.Inflammatory breast cancer in the Netherlands; improved survival over the last decades.Racial and Socioeconomic Disparities Are More Pronounced in Inflammatory Breast Cancer Than Other Breast Cancers.Influence of patient, physician, and hospital characteristics on the receipt of guideline-concordant care for inflammatory breast cancer.Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center
P2860
Q24817154-D91D7C3A-6907-4382-A1FA-0881919E4CD5Q33751139-93B13ECB-190B-45A8-90F1-56B815ADDCB5Q33781315-59A3F0F8-82AC-4B95-9648-0BAC2305B5D5Q34478105-73F54CE7-2713-41A0-B4CB-81291456C792Q34584856-0C2DD21B-EAEC-403A-81E4-757888E81193Q34782298-9D90EE58-677D-4908-B870-639D9CAF1789Q34918207-5B217971-8D52-41C7-A84D-09EBF4CB0989Q34918360-D2873FCF-3513-406B-A30A-B382AFC59241Q35572495-349FFA89-5EF7-4F27-A10D-EEC016DDE747Q35576639-8E35D6FF-66D5-4B5E-BC36-C83B5C1FE187Q35662191-A260AF4D-C2F0-43E6-8751-0EB47CB1D2E9Q36598732-0E771333-3720-4B8E-884E-E307887B057FQ37067432-54F27283-BAB9-49A4-8C55-780EA8CEFC79Q37092688-E25FC4C7-FF97-452A-856B-F48F02CD6294Q37210821-439406F4-BCB8-4C6F-9F7B-E93B2BEB713DQ37307189-2992265A-6B3D-434C-871D-499498359F41Q37463367-21E4D13E-ECD5-495D-BDD2-E8EC27AB5432Q37642758-958E7F7D-9C1B-4EE6-9FE9-240B4A13FB88Q37687112-3EF78DC4-5CF7-4BAC-88D7-7CC67164DEA4Q37687382-BA0F0327-7C56-496B-B46E-54BBDD195D1EQ38706762-A23C4814-F48E-4A6C-A1AC-3FEB7AD05E94Q39214862-D4ABEAC8-37F2-46C2-84EB-B16C157B126BQ40358255-DC4A2902-FE6C-4B46-BC2F-214A8F217EC8Q46046088-AE080636-3B9C-4E09-AA59-B314B756F08CQ55122090-84DA226B-EC52-4DC7-AE54-6ED0EF6830E9Q58701459-3E4D8F7E-0460-4244-9A9D-42F93073F1D0
P2860
Population-based statistics for women diagnosed with inflammatory breast cancer (United States).
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Population-based statistics fo ...... breast cancer (United States).
@ast
Population-based statistics fo ...... breast cancer (United States).
@en
Population-based statistics for women diagnosed with inflammatory breast cancer
@nl
type
label
Population-based statistics fo ...... breast cancer (United States).
@ast
Population-based statistics fo ...... breast cancer (United States).
@en
Population-based statistics for women diagnosed with inflammatory breast cancer
@nl
prefLabel
Population-based statistics fo ...... breast cancer (United States).
@ast
Population-based statistics fo ...... breast cancer (United States).
@en
Population-based statistics for women diagnosed with inflammatory breast cancer
@nl
P2093
P921
P1476
Population-based statistics fo ...... breast cancer (United States).
@en
P2093
John L Young
Patricia M Jamison
Paul Gargiullo
Phyllis A Wingo
P304
P356
10.1023/B:CACO.0000024222.61114.18
P577
2004-04-01T00:00:00Z
P6179
1018403019